{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hyper-ige-recurrent-infection-syndrome-4a-autosomal-dominant","columns":[{"gene":"","key":"population-66f16ec0eca4820adbfe","label":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","mondoId":"MONDO:0800131","onsetQualifier":null,"originColumnKey":"MONDO:0800131/OMIM:619752","originalViews":[{"key":"MONDO:0800131/OMIM:619752","label":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","scopeLabel":"OMIM:619752","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["05e27b8f6e4527fc6a7dbc7a668bfc0e5014a6f7fb745ed64a42f3e38ddb77b2","07669117015da019fe2ab21b370d77015e5c0a42c9499b4849ff7d3b8a7cf69a","0cb427c0588b81956bbf6a15619070d29362b10862bad062f13b7a94fafb0b1b","12b6e3c7391a1063d6d708546ac3ed7e40d4a3144b5bad9c8eaee708744fcaad","165fb5c72c2b904e94ec445253be6e9f2257ec9650cea3fc0821e8f293601b04","29df3ce9df4d41ff9b4fcac90006e68dbd5318b2ebbdd7669f7a66ca7cefecfb","3648354430ba0d05ae36332ff1faf5b0d9f01abcd9a7f694ffc6f78ba11cabbf","3a89a7b38647a65ad07627c77288ca2bc813394135318da4ba56377d9c5b2e26","3df502499ed1e424cfc2f49e99e15c3d66f2bec6e9c14d07e816dd2078de9a73","3e2708b85f73d6c397717c4b2187e9b4bc9d010ae8bc5f0169fe0b651f63817d","4b45496c611da52c9170b9d6855a8a470fbe6e0d40db7ae5020b93bac55c7a94","52cd31ff1006f9ce26c8a32203b4ea34a4b6b14e56ac3656cc12c5a26b525e78","554139c60d297531d3534e4bc2bea120f080feaaa7408502c1bbe5e4b791739b","584f8dd53c1759231310bce61da7ef94fbf17dbd300714c8e166db488b6e7a34","607e8b2e99bb4051db485a25299a31b2e9fde7107a0f0c5ce568b98f5e610474","6997848e9f151f457089eaf8ed6b42ea9171f57ddc773ba42be24e8e9267a095","82048ddaf5ad8b6024bed333d98190135c3ff51fe9c83fdef05dcb6eaf7b3e85","84b30a2f4eddbbf69c96f1108ba0b7b1728d67e83bf90070020629c8d48e9d28","85676e9ceb6219292f9cb3fecdc18b87767dfb2d2771f4146f0ddbe52b4eeb7d","8b96090ce7e386bb4b57661d75cc5fb252ced09dc6448e555ba661c5319dbd00","914282010433131459c14e72fd93904ab0a74518fb2adca362516eb3c01746f2","a6f01be0d90b644ecab0dd9096ccaae9168cf2a0cc6c355f385bd52f116c9857","b13ec26f82c339b27c0729694f841aff9f0acbd4bde96fca09422e0c657e756a","c1b0b4a60fa5b64d2b901592d7e7ab447c2168510896dd41fc18dc1f91c71e4a","dbbbd8715df7af3098c75c8858f22884502d97a3faf2d4f04da93eff8677f6e0","e272173d3a765ef35d5c2d8b4efa67bf3116b7a283e6544b80c692972e196222"],"recordQualifiers":{},"scopeLabel":"OMIM:619752","sourceIds":["OMIM:619752"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-66f16ec0eca4820adbfe"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0002099","HP:0001047","HP:0002110","HP:0002780","HP:0031292","HP:0002720","HP:0004315"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":26,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":26,"sourceGroups":{"published":26}},"features":[{"hpoId":"HP:0002099","label":"Asthma","primary":true},{"hpoId":"HP:0001047","label":"Atopic dermatitis","primary":true},{"hpoId":"HP:0002110","label":"Bronchiectasis","primary":true},{"hpoId":"HP:0002780","label":"Bronchomalacia","primary":true},{"hpoId":"HP:0031292","label":"Cutaneous abscess","primary":true},{"hpoId":"HP:0002720","label":"Decreased circulating IgA concentration","primary":true},{"hpoId":"HP:0004315","label":"Decreased circulating IgG concentration","primary":true},{"hpoId":"HP:0002850","label":"Decreased circulating IgM concentration","primary":false},{"hpoId":"HP:0001888","label":"Decreased total lymphocyte count","primary":false},{"hpoId":"HP:0001875","label":"Decreased total neutrophil count","primary":false},{"hpoId":"HP:0032434","label":"Delayed umbilical cord separation","primary":false},{"hpoId":"HP:0500093","label":"Food allergy","primary":false},{"hpoId":"HP:0000218","label":"High palate","primary":false},{"hpoId":"HP:0003212","label":"Increased circulating IgE concentration","primary":false},{"hpoId":"HP:0002659","label":"Increased susceptibility to fractures","primary":false},{"hpoId":"HP:0001382","label":"Joint hypermobility","primary":false},{"hpoId":"HP:0006335","label":"Persistence of primary teeth","primary":false},{"hpoId":"HP:0025419","label":"Pulmonary pneumatocele","primary":false},{"hpoId":"HP:0002728","label":"Recurrent mucocutaneous candidiasis","primary":false},{"hpoId":"HP:0006532","label":"Recurrent pneumonia","primary":false},{"hpoId":"HP:0001581","label":"Recurrent skin infections","primary":false},{"hpoId":"HP:0002788","label":"Recurrent upper respiratory tract infections","primary":false},{"hpoId":"HP:0040218","label":"Reduced total natural killer cell count","primary":false},{"hpoId":"HP:0002650","label":"Scoliosis","primary":false},{"hpoId":"HP:0011069","label":"Supernumerary tooth","primary":false},{"hpoId":"HP:0001762","label":"Talipes equinovarus","primary":false}],"ledeHtml":"An immunologic disorder characterized by recurrent mainly sinopulmonary infections associated with increased serum IgE. The phenotype is variable, even within families. Some patients have onset of symptoms in early childhood and develop complications, including bronchiectasis or hemoptysis, whereas others have later onset of less severe infections. Immunologic workup usually shows normal leukocyte levels, although some patients may demonstrate alterations in lymphocyte subsets, including T cells. Affected individuals also have variable skeletal abnormalities, including high-arched palate, hyperextensible joints, scoliosis, and bone fractures. The IL6ST mutations are loss-of-function, although the truncated mutant proteins are expressed and interfere with the wildtype protein in a dominant-negative manner by disrupting IL6 and IL11 signaling.","mondoId":"MONDO:0800131","node":{"canonicalSlug":"hyper-ige-recurrent-infection-syndrome-4a-autosomal-dominant","comparisons":[{"documentSha256":"5e659a51d932ff06a4da48ba85ec834e45cb714b86db014390ba235aae432693","key":"legacy-hyper-ige-recurrent-infection-syndrome-4a-autosomal-dominant","kind":"legacy","label":"hyper-IgE recurrent infection syndrome 4A, autosomal dominant","memberIds":["MONDO:0800131"],"mondoId":"MONDO:0800131","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hyper-ige-recurrent-infection-syndrome-4a-autosomal-dominant.5e659a51d932ff06a4da48ba85ec834e45cb714b86db014390ba235aae432693.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"hyper-IgE recurrent infection syndrome 4A, autosomal dominant","paragraphs":["An immunologic disorder characterized by recurrent mainly sinopulmonary infections associated with increased serum IgE. The phenotype is variable, even within families. Some patients have onset of symptoms in early childhood and develop complications, including bronchiectasis or hemoptysis, whereas others have later onset of less severe infections. Immunologic workup usually shows normal leukocyte levels, although some patients may demonstrate alterations in lymphocyte subsets, including T cells. Affected individuals also have variable skeletal abnormalities, including high-arched palate, hyperextensible joints, scoliosis, and bone fractures. The IL6ST mutations are loss-of-function, although the truncated mutant proteins are expressed and interfere with the wildtype protein in a dominant-negative manner by disrupting IL6 and IL11 signaling."],"scope":"exact","source":"MONDO","upstream":"OMIM:619752","url":"https://monarchinitiative.org/MONDO:0800131"},"ownColumnKeys":["population-66f16ec0eca4820adbfe"],"publication":"published","relationships":[{"kind":"parent","label":"hyper-IgE syndrome","mondoId":"MONDO:0018037","slug":"hyper-ige"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/26449"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"05e27b8f6e4527fc6a7dbc7a668bfc0e5014a6f7fb745ed64a42f3e38ddb77b2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"4/11","hpo_id":"HP:0002659","is_excluded":false,"label":"Increased susceptibility to fractures","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"07669117015da019fe2ab21b370d77015e5c0a42c9499b4849ff7d3b8a7cf69a","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"6/11","hpo_id":"HP:0025419","is_excluded":false,"label":"Pulmonary pneumatocele","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0cb427c0588b81956bbf6a15619070d29362b10862bad062f13b7a94fafb0b1b","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"1/11","hpo_id":"HP:0002728","is_excluded":false,"label":"Recurrent mucocutaneous candidiasis","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"12b6e3c7391a1063d6d708546ac3ed7e40d4a3144b5bad9c8eaee708744fcaad","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"4/12","hpo_id":"HP:0002720","is_excluded":false,"label":"Decreased circulating IgA concentration","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"165fb5c72c2b904e94ec445253be6e9f2257ec9650cea3fc0821e8f293601b04","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"1/12","hpo_id":"HP:0001888","is_excluded":false,"label":"Decreased total lymphocyte count","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"29df3ce9df4d41ff9b4fcac90006e68dbd5318b2ebbdd7669f7a66ca7cefecfb","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"10/11","hpo_id":"HP:0006532","is_excluded":false,"label":"Recurrent pneumonia","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3648354430ba0d05ae36332ff1faf5b0d9f01abcd9a7f694ffc6f78ba11cabbf","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"6/11","hpo_id":"HP:0002650","is_excluded":false,"label":"Scoliosis","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3a89a7b38647a65ad07627c77288ca2bc813394135318da4ba56377d9c5b2e26","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"1/12","hpo_id":"HP:0001875","is_excluded":false,"label":"Decreased total neutrophil count","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3df502499ed1e424cfc2f49e99e15c3d66f2bec6e9c14d07e816dd2078de9a73","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"4/11","hpo_id":"HP:0031292","is_excluded":false,"label":"Cutaneous abscess","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3e2708b85f73d6c397717c4b2187e9b4bc9d010ae8bc5f0169fe0b651f63817d","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"8/11","hpo_id":"HP:0001047","is_excluded":false,"label":"Atopic dermatitis","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4b45496c611da52c9170b9d6855a8a470fbe6e0d40db7ae5020b93bac55c7a94","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"1/12","hpo_id":"HP:0002780","is_excluded":false,"label":"Bronchomalacia","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"52cd31ff1006f9ce26c8a32203b4ea34a4b6b14e56ac3656cc12c5a26b525e78","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"3/11","hpo_id":"HP:0000218","is_excluded":false,"label":"High palate","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"554139c60d297531d3534e4bc2bea120f080feaaa7408502c1bbe5e4b791739b","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"6/11","hpo_id":"HP:0002788","is_excluded":false,"label":"Recurrent upper respiratory tract infections","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"584f8dd53c1759231310bce61da7ef94fbf17dbd300714c8e166db488b6e7a34","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"2/12","hpo_id":"HP:0004315","is_excluded":false,"label":"Decreased circulating IgG concentration","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"607e8b2e99bb4051db485a25299a31b2e9fde7107a0f0c5ce568b98f5e610474","raw":{"aspect":"P","body_system":"prenatal","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"1/12","hpo_id":"HP:0032434","is_excluded":false,"label":"Delayed umbilical cord separation","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6997848e9f151f457089eaf8ed6b42ea9171f57ddc773ba42be24e8e9267a095","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"2/12","hpo_id":"HP:0002850","is_excluded":false,"label":"Decreased circulating IgM concentration","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"82048ddaf5ad8b6024bed333d98190135c3ff51fe9c83fdef05dcb6eaf7b3e85","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"3/12","hpo_id":"HP:0011069","is_excluded":false,"label":"Supernumerary tooth","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"84b30a2f4eddbbf69c96f1108ba0b7b1728d67e83bf90070020629c8d48e9d28","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"6/10","hpo_id":"HP:0002110","is_excluded":false,"label":"Bronchiectasis","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"85676e9ceb6219292f9cb3fecdc18b87767dfb2d2771f4146f0ddbe52b4eeb7d","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"4/12","hpo_id":"HP:0001581","is_excluded":false,"label":"Recurrent skin infections","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"8b96090ce7e386bb4b57661d75cc5fb252ced09dc6448e555ba661c5319dbd00","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"1/11","hpo_id":"HP:0500093","is_excluded":false,"label":"Food allergy","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"914282010433131459c14e72fd93904ab0a74518fb2adca362516eb3c01746f2","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"2/12","hpo_id":"HP:0040218","is_excluded":false,"label":"Reduced total natural killer cell count","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a6f01be0d90b644ecab0dd9096ccaae9168cf2a0cc6c355f385bd52f116c9857","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0003212","is_excluded":false,"label":"Increased circulating IgE concentration","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b13ec26f82c339b27c0729694f841aff9f0acbd4bde96fca09422e0c657e756a","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"8/12","hpo_id":"HP:0002099","is_excluded":false,"label":"Asthma","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c1b0b4a60fa5b64d2b901592d7e7ab447c2168510896dd41fc18dc1f91c71e4a","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"9/11","hpo_id":"HP:0006335","is_excluded":false,"label":"Persistence of primary teeth","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"dbbbd8715df7af3098c75c8858f22884502d97a3faf2d4f04da93eff8677f6e0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"2/11","hpo_id":"HP:0001762","is_excluded":false,"label":"Talipes equinovarus","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e272173d3a765ef35d5c2d8b4efa67bf3116b7a283e6544b80c692972e196222","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:619752","disease_name":"Hyper-IgE recurrent infection syndrome 4A, autosomal dominant","evidence":"PCS","frequency_raw":"7/11","hpo_id":"HP:0001382","is_excluded":false,"label":"Joint hypermobility","onset_id":null,"reference":"PMID:32207811","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0800131\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>OMIM:619752</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>An immunologic disorder characterized by recurrent mainly sinopulmonary infections associated with increased serum IgE. The phenotype is variable, even within families. Some patients have onset of symptoms in early childhood and develop complications, including bronchiectasis or hemoptysis, whereas others have later onset of less severe infections. Immunologic workup usually shows normal leukocyte levels, although some patients may demonstrate alterations in lymphocyte subsets, including T cells. Affected individuals also have variable skeletal abnormalities, including high-arched palate, hyperextensible joints, scoliosis, and bone fractures. The IL6ST mutations are loss-of-function, although the truncated mutant proteins are expressed and interfere with the wildtype protein in a dominant-negative manner by disrupting IL6 and IL11 signaling.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0800131\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hyper-ige-recurrent-infection-syndrome-4a-autosomal-dominant","sourceDocuments":[{"name":"MONDO: hyper-IgE recurrent infection syndrome 4A, autosomal dominant","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0800131"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"hyper-IgE recurrent infection syndrome 4A, autosomal dominant"},"schemaVersion":1}
